IndraLab

Statements


Hydroxychloroquine inhibits HbA1c. 4 / 4
| 4

reach
"In patients with type 2 diabetes on insulin therapy, hydroxychloroquine was also found to significantly reduce HbA1c compared to placebo at 6 months of follow-up [XREF_BIBR]."

reach
"Even in another Indian trial hydroxychloroquine 400mg reduced HbA1c at tune of 1.3% whereas hydroxychloroquine 200mg reduced the same by o. 8% over 24week [XREF_BIBR]."

reach
"The results showed that HCQ decreased HbA1c and improved glucose tolerance without significant adverse effects during the first 6 months of treatment [59]."

reach
"However, hydroxychloroquine (HCQ), a broad anti-inflammatory agent has been shown to reduce HbA1c by 0.87%."